Spruce Biosciences SPRB

$ 0.49 -0.79%

Quarterly report 2024-Q3
added 11-12-2024

Spruce Biosciences Income Statement 2011-2024 | SPRB

Annual Income Statement Spruce Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	29.3 M	53.6 M	104 M	462 M	-	-	-	-	-	-	-	-	-
Shares	38.5 M	23.5 M	23.4 M	22.3 M	-	-	-	-	-	-	-	-	-
Historical Prices	0.76	2.28	4.46	24.3	-	-	-	-	-	-	-	-	-
Net Income	-47.9 M	-46.2 M	-42.3 M	-29.5 M	-13.1 M	-9.86 M	-	-	-	-	-	-	-
Revenue	10.1 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-52 M	-47.3 M	-42.1 M	-29.4 M	-13.1 M	-	-	-	-	-	-	-	-
Interest Expense	483 K	420 K	345 K	323 K	65 K	-	-	-	-	-	-	-	-
EBITDA	-51.9 M	-47.2 M	-42 M	-29.4 M	-13.1 M	-9.97 M	-	-	-	-	-	-	-
Operating Expenses	62.1 M	47.3 M	42.1 M	29.4 M	13.1 M	9.97 M	-	-	-	-	-	-	-
General and Administrative Expenses	12.6 M	12.1 M	11.4 M	5.56 M	2.29 M	1.57 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Spruce Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	41.3 M	41.2 M	41.1 M	41 M	40.7 M	40.5 M	31.9 M	23.6 M	23.6 M	23.5 M	23.5 M	23.5 M	23.4 M	23.3 M	23.3 M	23.3 M	776 K	764 K	764 K	764 K	764 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-8.67 M	-9.18 M	-11.6 M	-	-12.4 M	-12.8 M	-12.8 M	-	-11.4 M	-11.9 M	-11.8 M	-	-11.4 M	-11.8 M	-9.89 M	-	-9.59 M	-6.45 M	-5.17 M	-	-2.55 M	-3.24 M	-4.12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	602 K	1.61 M	2 M	-	3.07 M	2.16 M	1.96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-9.41 M	-10 M	-12.6 M	-	-13.7 M	-14 M	-13.2 M	-	-11.6 M	-11.9 M	-11.7 M	-	-11.4 M	-11.7 M	-9.82 M	-	-9.56 M	-6.39 M	-5.13 M	-	-2.56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	71 K	83 K	97 K	-	119 K	127 K	131 K	-	110 K	94 K	87 K	-	88 K	80 K	89 K	-	79 K	92 K	74 K	-	5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-12.6 M	-	-	-	-13.2 M	-	-11.5 M	-11.9 M	-11.7 M	-	-11.4 M	-11.7 M	-9.8 M	-	-9.53 M	-6.37 M	-5.13 M	-	-2.56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	10 M	11.6 M	14.6 M	-	16.7 M	16.1 M	15.2 M	-	11.6 M	11.9 M	11.7 M	-	11.4 M	11.7 M	9.82 M	-	9.56 M	6.39 M	5.13 M	-	2.56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.46 M	3.56 M	4.32 M	-	3.24 M	3.01 M	3.45 M	-	2.77 M	2.82 M	3.22 M	-	2.79 M	2.6 M	3.1 M	-	1.79 M	727 K	523 K	-	457 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency